3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Colorectal Neoplasms
127
Colonic Neoplasms
71
Rectal Neoplasms
56
Neoplasm Metastasis
22
Pancreatic Neoplasms
21
Stomach Neoplasms
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Leukemia
11
Carcinoma, Hepatocellular
11
Neoplasms
10
Lymphoma
10
Burkitt Lymphoma
8
Adenocarcinoma Of Esophagus
8
Cholangiocarcinoma
6
Adenocarcinoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Esophageal Neoplasms
5
Leukemia, Biphenotypic, Acute
4
Intestinal Neoplasms
4
Gastrointestinal Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Digestive System Neoplasms
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large B-Cell, Diffuse
3
Gallbladder Neoplasms
3
Biliary Tract Neoplasms
3
Rectal Diseases
2
Neurotoxicity Syndromes
2
Interventions
Doxorubicin
6
Dexrazoxane
6
Razoxane
5
Vincristine
4
Cyclophosphamide
4
Radiotherapy
3
Etoposide
3
Prednisone
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Carvedilol
2
Bleomycin
2
schizandrin
1
pegfilgrastim
1
hydrocortisone hemisuccinate
1
fructus schizandrae, radix ginseng, radix ophiopogonis drug combination
1
empagliflozin
1
Watchful Waiting
1
VAP-cyclo protocol
1
Trastuzumab
1
Taxes
1
Tamoxifen
1
Rituximab
1
Ramipril
1
Radiation
1
Prednisolone
1
Paclitaxel
1
Observation
1
Neoadjuvant Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Cardiotoxicity
×
Leucovorin
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled